Search results
The Zacks Analyst Blog Highlights Novavax, ALX Oncology, Regeneron Pharmaceuticals, Intellia and...
Zacks via Yahoo Finance· 7 months agoFor Immediate Release Chicago, IL – October 6, 2023 – Zacks.com announces the list of stocks...
Novavax (NVAX) Beats on Q3 Earnings & Sales, Cuts Sales View
Zacks via Yahoo Finance· 6 months agoNovavax (NVAX) reports better-than-expected third-quarter results, with earnings and revenues...
Novavax Stock Is Too Sickly To Buy
InvestorPlace via Yahoo Finance· 2 years agoNovavax’s Covid-19 vaccine still isn’t approved for use in the U.S. With the pandemic in full retreat and the majority of people now fully vaccinated,...
The Zacks Analyst Blog Highlights Regeneron Pharmaceuticals, Gilead Sciences, Novavax, Apellis...
Zacks via Yahoo Finance· 8 months agoFor Immediate Release Chicago, IL – August 25, 2023 – Zacks.com announces the list of stocks...
Novavax (NVAX) Q4 Earnings & Sales Miss Estimates, Stock Tanks
Zacks via Yahoo Finance· 2 months agoNovavax, Inc. NVAX reported a fourth-quarter 2023 loss of $1.44 cents per share, much wider than the...
Novavax (NVAX) Q1 Earnings Lag, Stock Up 28% on Upbeat '23 View
Zacks via Yahoo Finance· 12 months agoNovavax (NVAX) reports dismal Q1 earnings results, as earnings and revenues miss estimates. However,...
Novavax (NVAX) to Report Q4 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 1 year agoWe expect investors to focus on the sales performance of Novavax, Inc.’s NVAX protein-based COVID-19...
Novavax's new COVID vaccine cleared for use by FDA
Live Science via Yahoo News· 7 months agoClose up of a person's hand as they extract vaccine from a vial labeled "novavax". The Food and Drug Administration (FDA) has authorized a new...
Novavax (NVAX) Names John Jacobs as New CEO, Shares Rise
Zacks via Yahoo Finance· 1 year agoShares of small-biotech Novavax, Inc. NVAX were up 11.3% on Monday after the company announced that...
Why Novavax Stock Tumbled 28% in the First Half of 2023
Motley Fool· 10 months agoWhat happened Shares of Novavax (NASDAQ: NVAX) lost 28% of their value in the first six months of...